Query

Active Filters

  • (-) PSI Laboratories = Center for Radiopharmaceutical Sciences ZRW
Search Results 1 - 20 of 231

Pages

  • RSS Feed
Select Page
Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities
Benešová, M., Guzik, P., Deberle, L. M., Busslinger, S. D., Landolt, T., Schibli, R., & Müller, C. (2022). Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities. Molecular Pharmaceutics, 19, 963-973. https://doi.org/10.1021/acs.molpharmaceut.1c00932
Combination of terbium-161 with somatostatin receptor antagonists - a potential paradigm shift for the treatment of neuroendocrine neoplasms
Borgna, F., Haller, S., Monné Rodriguez, J. M., Ginj, M., Grundler, P. V., Zeevaart, J. R., … Müller, C. (2022). Combination of terbium-161 with somatostatin receptor antagonists - a potential paradigm shift for the treatment of neuroendocrine neoplasms. European Journal of Nuclear Medicine and Molecular Imaging, 49, 1113-1126. https://doi.org/10.1007/s00259-021-05564-0
Preclinical investigations to explore the difference between the diastereomers [<sup>177</sup>Lu]Lu-SibuDAB and [<sup>177</sup>Lu]Lu-RibuDAB toward prostate cancer therapy
Borgna, F., Deberle, L. M., Busslinger, S. D., Tschan, V. J., Walde, L. M., Becker, A. E., … Müller, C. (2022). Preclinical investigations to explore the difference between the diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward prostate cancer therapy. Molecular Pharmaceutics, 19(7), 2105-2114. https://doi.org/10.1021/acs.molpharmaceut.1c00994
Optimization of <sup>68</sup>Ga production at an 18 MeV medical cyclotron with solid targets by means of cross-section measurement of <sup>66</sup>Ga, <sup>67</sup>Ga and <sup>68</sup>Ga
Braccini, S., Carzaniga, T. S., Dellepiane, G., Grundler, P. V., Scampoli, P., van der Meulen, N. P., & Wüthrich, D. (2022). Optimization of 68Ga production at an 18 MeV medical cyclotron with solid targets by means of cross-section measurement of 66Ga, 67Ga and 68Ga. Applied Radiation and Isotopes, 186, 110252 (9 pp.). https://doi.org/10.1016/j.apradiso.2022.110252
Biodegradable ultrasmall-in-nano architectures loaded with cisplatin prodrug in combination with ionizing radiation induces DNA damage and apoptosis in pancreatic ductal adenocarcinoma
Che, P. P., Mapanao, A. K., Gregori, A., Ermini, M. L., Zamborlin, A., Capula, M., … Giovannetti, E. (2022). Biodegradable ultrasmall-in-nano architectures loaded with cisplatin prodrug in combination with ionizing radiation induces DNA damage and apoptosis in pancreatic ductal adenocarcinoma. Cancers, 14(12), 3034 (17 pp.). https://doi.org/10.3390/cancers14123034
High precision half-life measurement of the extinct radio-lanthanide Dysprosium-154
Chiera, N. M., Dressler, R., Sprung, P., Talip, Z., & Schumann, D. (2022). High precision half-life measurement of the extinct radio-lanthanide Dysprosium-154. Scientific Reports, 12(1), 8988 (10 pp.). https://doi.org/10.1038/s41598-022-12684-6
Cross section measurement of terbium radioisotopes for an optimized <sup>155</sup>Tb production with an 18 MeV medical PET cyclotron
Dellepiane, G., Casolaro, P., Favaretto, C., Grundler, P. V., Mateu, I., Scampoli, P., … Braccini, S. (2022). Cross section measurement of terbium radioisotopes for an optimized 155Tb production with an 18 MeV medical PET cyclotron. Applied Radiation and Isotopes, 184, 110175 (14 pp.). https://doi.org/10.1016/j.apradiso.2022.110175
Preliminary discovery of small molecule inhibitors of Epidermal Growth Factor Receptor (EGFR) that bind to the extracellular domain
Di Liddo, R., Verona, M., Vaccarin, C., Acquasaliente, L., Schrenk, S., Piccione, M., … Marzaro, G. (2022). Preliminary discovery of small molecule inhibitors of Epidermal Growth Factor Receptor (EGFR) that bind to the extracellular domain. Cancers, 14(15), 3647 (22 pp.). https://doi.org/10.3390/cancers14153647
EANM guideline on quality risk management for radiopharmaceuticals
Gillings, N., Hjelstuen, O., Behe, M., Decristoforo, C., Elsinga, P. H., Ferrari, V., … Walte, A. (2022). EANM guideline on quality risk management for radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging, 49, 3353-3364. https://doi.org/10.1007/s00259-022-05738-4
Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161
Juget, F., Talip, Z., Nedjadi, Y., Durán, M. T., Grundler, P. V., Zeevaart, J. R., … Bailat, C. (2022). Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161. EJNMMI Physics, 9(1), 19 (18 pp.). https://doi.org/10.1186/s40658-022-00448-0
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects
Miller, I. S., Khan, S., Shiels, L. P., Das, S., O' Farrell, A. C., Connor, K., … Byrne, A. T. (2022). Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects. Cancer Medicine (17 pp.). https://doi.org/10.1002/cam4.4756
A multispecific anti-CD40 DARPin construct induces tumor-selective CD40 activation and tumor regression
Rigamonti, N., Veitonmäki, N., Domke, C., Barsin, S., Jetzer, S., Abdelmotaleb, O., … Trail, P. A. (2022). A multispecific anti-CD40 DARPin construct induces tumor-selective CD40 activation and tumor regression. Cancer Immunology Research, 10(5), 626-640. https://doi.org/10.1158/2326-6066.CIR-21-0553
Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
Schmitt, J., Schwenck, J., Maurer, A., Przybille, M., Sonanini, D., Reischl, G., … Pichler, B. J. (2022). Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma. Theranostics, 12(13), 5615-5630. https://doi.org/10.7150/thno.56736
Chelation of theranostic copper radioisotopes with S-rich macrocycles: from radiolabelling of copper-64 to in vivo investigation
Tosato, M., Verona, M., Favaretto, C., Pometti, M., Zanoni, G., Scopelliti, F., … Asti, M. (2022). Chelation of theranostic copper radioisotopes with S-rich macrocycles: from radiolabelling of copper-64 to in vivo investigation. Molecules, 27(13), 4158 (19 pp.). https://doi.org/10.3390/molecules27134158
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands
Tschan, V. J., Borgna, F., Schibli, R., & Müller, C. (2022). Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands. European Journal of Nuclear Medicine and Molecular Imaging, 49, 470-480. https://doi.org/10.1007/s00259-021-05446-5
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer
Tschan, V. J., Borgna, F., Busslinger, S. D., Stirn, M., Monné Rodriguez, J. M., Bernhardt, P., … Müller, C. (2022). Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 49, 3639-3650. https://doi.org/10.1007/s00259-022-05837-2
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Aime, S., Al-Qahtani, M., Behe, M., Bormans, G., Carlucci, G., DaSilva, J. N., … Yang, Z. (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharmacy and Chemistry, 6(1), 13 (19 pp.). https://doi.org/10.1186/s41181-021-00128-x
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020)
Al-Qahtani, M., Behe, M., Bormans, G., Carlucci, G., Dasilva, J., Decristoforo, C., … Vugts, D. (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020). EJNMMI Radiopharmacy and Chemistry, 6(1), 5 (13 pp.). https://doi.org/10.1186/s41181-020-00118-5
First-in-human application of terbium-161: a feasibility study using <sup>161</sup>Tb-DOTATOC
Baum, R. P., Singh, A., Kulkarni, H. R., Bernhardt, P., Rydén, T., Schuchardt, C., … Müller, C. (2021). First-in-human application of terbium-161: a feasibility study using 161Tb-DOTATOC. Journal of Nuclear Medicine, 62(10), 1391-1397. https://doi.org/10.2967/jnumed.120.258376
Dosimetric analysis of the short-ranged particle emitter <sup>161</sup>Tb for radionuclide therapy of metastatic prostate cancer
Bernhardt, P., Svensson, J., Hemmingsson, J., van der Meulen, N. P., Zeevaart, J. R., Konijnenberg, M. W., … Kindblom, J. (2021). Dosimetric analysis of the short-ranged particle emitter 161Tb for radionuclide therapy of metastatic prostate cancer. Cancers, 13(9), 2011 (13 pp.). https://doi.org/10.3390/cancers13092011
 

Pages